Cancer risk among shift workers: A review;Rischio oncogeno nei lavoratori a turni: Analisi della letteratura

Giornale Italiano di Medicina del Lavoro ed Ergonomia

Volumn 34, Issue 3, 2012, Pages 624-626

  Puligheddu, M ^a   Conti, S ^a   Campagna, M ^a   Meloni, M ^a   Pau, M ^a   Cocco, P ^a   Marrosu, F ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Carcinogenesis; Genetic polymorphisms; Shift work

Indexed keywords

ARTICLE; HUMAN; NEOPLASM; OCCUPATIONAL DISEASE; RISK FACTOR; WORK SCHEDULE;

HUMANS; NEOPLASMS; OCCUPATIONAL DISEASES; RISK FACTORS; WORK SCHEDULE TOLERANCE;

EID: 84868336608     PISSN: 15927830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Istituto Nazionale di Statistica: Flessibilità dell'orario e organizzazione del lavoro. Il modulo ad hoc della Rilevazione sulle forze di lavoro del II trimestre 2004. Roma: ISTAT, 2005 (Statistiche in breve, 29 /12/ 2005). http://www.istat.it/salastampa/comunicatilnon-calendario/20051229-00/ testninteqrale.pdf.
2. Wang XS, Armstrong ME, Cairns BJ, Key TJ, Travis RC. Shift work and chronic disease: the epidemiological evidence. Occup Med (Lond) 2011;61:78-8.
3. International Agency for Research on Cancer. Painting, Firefighting, and Shiftwork. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. Vol. 98. Lyon, France: IARC, 2010, pp 561-764.
4. Fritschi L, Glass DC, Heyworth JS, Aronson K, Girschik J, Boyle T, Grundy A. Hypotheses for mechanisms linking shiftwork and cancer. Med Hypotheses 2011;77: 430-6.
5. Hoffman AE, Zheng T, Stevens RG, Ba Y, Zhang Y, Leadere, D, Yi C., Holford TR, Zhu Y. Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Cancer Res 2009;69: 3605-13.
6. Kuo S-J, Chen S-T, Yeh K-T, Hou M-F, Chang Y-S, Hsu NC, Chang J-G. Disturbance of circadian gene expression in breast cancer. Virchow Arch 2009;454: 467-74.
7. Lin Y-M, Chang JH, Yeh K-T, Yang M-Y, Liu T-C, Lin S-F, Su W-W, Chang JG. Disturbance of circadian gene expression in hepatocellular carcinoma. Mol Carcinog 2008;47: 925-33.
8. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003;3: 350-61.
9. Vijayalaxmi, Thomas CR Jr, Reiter RJ, Herman TS. Melatonin: from basic research to cancer treatment clinics. Journal of Clinical Oncology 2002;20: 2575-601.
10. Reiter RJ. Mechanisms of cancer inhibition by melatonin. J Pineal Res 2004;37:213-4.
11. Mills E, Wu P, Seely D, Guyatt G. Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and metaanalysis. J Pineal Res. 2005;39:360-6.
12. Kryger MH, Roth T, Dement WC. Principles and practice of sleep medicine. 5th Edition. St Louis, MO: Elsevier Saunders, 2011.
13. Dimitrov S, Lange T, Tieken S, Fehm, HL, Born J. Sleep associated regulation of T helper 1/T helper 2 cytokine balance in humans. Brain Behav Immun 2004;18: 341-8.
14. Bovbjerg DH. Circadian disruption and cancer: sleep and immune regulation. Brain Behav Immun 2003; 17 Suppl 1:S48-50.
15. Knutsson A. Shift work and coronary heart disease. Scand J Soc Med 1989;44Suppl.:1-36.
16. Fleet JC, DeSmet M, Johnson R, Li Y. Vitamin D and cancer: a review of molecular mechanisms. Biochem J 2012;441:61-76.
17. Lerchl A. Schindler C., Eichhorn K, Kley F. Erren TC. Indirect blue light does not suppress nocturnal salivary melatonin in humans in an automobile setting. J Pineal Res 2009;47:143-6.